Rucacuzumab plus standard therapy
1-24PJ2600
Approved small_molecule active
Quick answer
Rucacuzumab plus standard therapy for Acute Ischemic Stroke AIS is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Acute Ischemic Stroke AIS
- Phase
- Approved
- Modality
- small_molecule
- Status
- active